DGX Net income
Net income at Quest Diagnostics rose to $992M in fiscal 2025, from $871M in 2024.
Net income attributable to the parent / common stockholders, as filed.
SOURCE: us-gaap:NetIncomeLoss · EDGAR CompanyFacts · CIK 1022079 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
FY2025$992M
FY2024 $871M
HIGH$2.0B FY2021
LOW$854M FY2023
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Net income | Change |
|---|---|---|
| FY2025 | $992M | +$121M |
| FY2024 | $871M | +$17M |
| FY2023 | $854M | $-92M |
| FY2022 | $946M | $-1.0B |
| FY2021 | $2.0B | — |
More SAME DATA, OTHER VIEWS
Net income across coverage → · DGX company view →
Revenue · Operating cash flow · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.